DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $850,239 | +2.6% | 3,427 | -0.8% | 0.00% | +33.3% |
| Q2 2023 | $828,720 | -15.6% | 3,453 | -11.3% | 0.00% | -25.0% |
| Q1 2023 | $981,696 | -79.5% | 3,895 | -78.4% | 0.00% | -82.6% |
| Q4 2022 | $4,792,424 | -2.4% | 18,056 | -5.0% | 0.02% | -8.0% |
| Q3 2022 | $4,911,000 | -34.2% | 19,014 | -35.4% | 0.02% | -32.4% |
| Q2 2022 | $7,459,000 | -65.5% | 29,421 | -60.0% | 0.04% | -56.5% |
| Q1 2022 | $21,595,000 | -7.8% | 73,619 | +3.4% | 0.08% | -2.3% |
| Q4 2021 | $23,423,000 | +8.5% | 71,192 | +0.4% | 0.09% | -12.1% |
| Q3 2021 | $21,583,000 | +37.5% | 70,894 | +21.2% | 0.10% | +43.5% |
| Q2 2021 | $15,700,000 | -25.5% | 58,503 | -37.5% | 0.07% | -27.4% |
| Q1 2021 | $21,066,000 | -32.2% | 93,592 | -33.1% | 0.10% | -28.6% |
| Q4 2020 | $31,092,000 | -20.0% | 139,966 | -22.5% | 0.13% | -25.7% |
| Q3 2020 | $38,878,000 | +6.8% | 180,551 | -12.3% | 0.18% | +2.3% |
| Q2 2020 | $36,417,000 | +393.1% | 205,946 | +285.9% | 0.18% | +272.3% |
| Q1 2020 | $7,386,000 | +979.8% | 53,362 | +1097.0% | 0.05% | +1466.7% |
| Q4 2019 | $684,000 | -97.0% | 4,458 | -97.1% | 0.00% | -97.5% |
| Q3 2019 | $22,585,000 | -1.7% | 156,370 | -2.8% | 0.12% | -0.8% |
| Q2 2019 | $22,984,000 | +11.6% | 160,818 | +3.1% | 0.12% | +7.9% |
| Q1 2019 | $20,586,000 | +31.6% | 155,928 | +2.8% | 0.11% | +17.5% |
| Q4 2018 | $15,645,000 | -4.6% | 151,718 | +0.5% | 0.10% | +12.8% |
| Q3 2018 | $16,403,000 | +34.1% | 150,953 | +21.8% | 0.09% | +26.5% |
| Q2 2018 | $12,235,000 | +0.6% | 123,983 | -0.2% | 0.07% | -1.4% |
| Q1 2018 | $12,167,000 | -46.1% | 124,263 | -48.9% | 0.07% | -43.9% |
| Q4 2017 | $22,579,000 | -37.3% | 243,257 | -42.0% | 0.12% | -40.9% |
| Q3 2017 | $36,004,000 | +11.9% | 419,728 | +10.1% | 0.21% | +3.0% |
| Q2 2017 | $32,186,000 | +503.8% | 381,390 | +511.9% | 0.20% | +417.9% |
| Q1 2017 | $5,331,000 | -30.6% | 62,332 | -36.8% | 0.04% | -35.0% |
| Q4 2016 | $7,678,000 | -28.7% | 98,638 | -28.2% | 0.06% | -33.3% |
| Q3 2016 | $10,762,000 | -32.2% | 137,291 | -12.6% | 0.09% | -33.3% |
| Q2 2016 | $15,866,000 | +8.0% | 157,093 | +1.5% | 0.14% | +3.1% |
| Q1 2016 | $14,684,000 | +3.9% | 154,798 | +1.7% | 0.13% | +1.6% |
| Q4 2015 | $14,137,000 | +721.0% | 152,212 | +653.3% | 0.13% | +658.8% |
| Q3 2015 | $1,722,000 | -0.4% | 20,206 | 0.0% | 0.02% | +6.2% |
| Q2 2015 | $1,729,000 | +0.8% | 20,206 | 0.0% | 0.02% | 0.0% |
| Q1 2015 | $1,715,000 | -17.5% | 20,206 | -16.6% | 0.02% | -15.8% |
| Q4 2014 | $2,078,000 | +45.4% | 24,241 | +28.9% | 0.02% | +11.8% |
| Q3 2014 | $1,429,000 | -88.6% | 18,804 | -88.2% | 0.02% | -86.0% |
| Q2 2014 | $12,579,000 | -9.3% | 159,773 | -13.6% | 0.12% | -19.9% |
| Q1 2014 | $13,864,000 | -3.9% | 184,848 | -1.1% | 0.15% | -6.2% |
| Q4 2013 | $14,424,000 | -9.0% | 186,835 | -18.3% | 0.16% | -17.9% |
| Q3 2013 | $15,853,000 | -42.4% | 228,690 | -47.4% | 0.20% | -49.6% |
| Q2 2013 | $27,511,000 | – | 434,607 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |